Quick access to main page (top) Direct access to main contents Quick access to main page (bottom)

KF-21: South Korea’s Weapon Against North Korea’s Provocations – Part 1

Daniel Kim Views  

단 1발로 北 도발 꺾을 KF-21 장착될 ‘독침무기’는[이현호 기자의 밀리터리!톡]
The KF-21, a domestic fighter jet, was on display at the Seoul ADEX 2023 event at Seoul Airport in Seongnam, Gyeonggi Province, on October 17 last year. Yonhap News

The KF-21 (Boramae), the first domestic fighter jet, is the largest weapons project since Dangun, with a total project cost of $13.7 billion. The KF-21, also known as the Korean Fighter (KF-X) project, effectively started in August 2001 when President Kim Dae Jung declared that he would develop a domestic fighter jet by 2015.

The KF-21 can freely develop and equip various domestic weapons, such as air-to-air missiles, which will undoubtedly enhance the stature of our Air Force as the first domestic fighter jet.

The so-called KF-X project is about a medium-grade fighter with performance superior to the KF-16. Although it is a 4th-generation fighter, it has some 5th-generation stealth capabilities, making it rated as a 4.5-generation fighter. Its exterior is specially made in a stealth shape to minimize radar reflection, similar to the world’s most powerful stealth fighter, the US F-22 Raptor. It is sometimes referred to as the “Baby Raptor.”

With a length of 16.9m and a height of 4.7m, it is larger than the US F-16 and F-35 stealth fighters but smaller than the F-15 and F-22. Its maximum payload is 17,000 lbs, its top speed is Mach 1.81, and its range extends to 1,800 miles. By 2026, $6.18 billion will be invested in the development of “Block 1,” which focuses on air-to-air combat capabilities, and an additional $534 million will be invested in the “Block 2” additional armament test, which the Korean military is pushing for alone from 2026 to 2028. The total project cost, including the production cost of 120 aircraft, will amount to $13.7 billion, making it the “largest defense enhancement project since Dangun.”

Part 2…
Part 3…

Daniel Kim
content@viewusglobal.com

Comments0

300

Comments0

[ASIA] Latest Stories

  • Hyundai Ioniq 5 N Time Spec Breaks Tsukuba Circuit Record, Cementing EV Performance Legacy
  • North Korea Sends Young Volunteers to Dangerous Jobs Under the Guise of Voluntary Participation
  • Tension Soars in South Korea’s Presidential Security: Arming Guards with Heavy Weapons After Resignation
  • Democrats Call for Accountability, Push to Investigate Yoon’s ‘Bloodshed’ Tactics
  • Hundreds of Trucks Deliver Scrap Metal Across North Korea for New Year Push
  • 1 Million Chinese Citizens Apply for Asylum During Xi’s Rule, As Repression Increases

You May Also Like

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE&nbsp

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE&nbsp

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE&nbsp

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE&nbsp

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE&nbsp

Must-Reads

  • 1
    FDA Greenlights Sanofi's Qfitlia for Hemophilia—An Innovative Alternative to Daily Injections

    LIFESTYLE 

  • 2
    Prostate Cancer Screenings May Cut Death Risk in Half, Study Finds

    LIFESTYLE 

  • 3
    It’s Not Just Depression: Personality Disorders Linked to Highest Suicide Risk

    LIFESTYLE 

  • 4
    Faster Cancer Treatment? Merck Launch Set for Subcutaneous Keytruda Rollout

    LIFESTYLE 

  • 5
    Cutting Carbs? You Might Be Raising Your Risk of Colon Cancer

    LIFESTYLE 

Popular Now

  • 1
    Tired of the Buzz? Fruit and Dairy Might Help, New Study Says

    LIFESTYLE 

  • 2
    Study Finds Missing Gut Bacteria in Parkinson’s and IBD Patients

    LIFESTYLE 

  • 3
    New Research Reveals Ketogenic Diet Slows Biological Aging by 6+ Years

    LIFESTYLE 

  • 4
    New Drug Cuts Heart Disease Risk by 94%—And Has No Major Side Effects

    LIFESTYLE 

  • 5
    Wegovy Maker Strikes $1B Deal for Next-Gen Obesity Treatment

    LIFESTYLE